Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John G. Freund
AddedMar 31, 2024
UpdatedJun 28, 2026
John G. Freund

John G. Freund

Advisor, Medical Devices Corner

CrunchbaseLinkedIn

John G. Freund's Career

Medical Devices Corner
Medical Devices Corner

Menlo Park, CA, US

Advisor
Sutro Biopharma
Sutro Biopharma

South San Francisco, CA, US

Board Member· Board
Intuitive Surgical
Intuitive Surgical

Sunnyvale, CA, US

Co-Founder
Arixa Pharmaceuticals
Arixa Pharmaceuticals

Palo Alto, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John G. Freund's Career

Medical Devices Corner
Medical Devices Corner
Seed142021Menlo Park, CA, US
Advisor

Recent news

Bringing surgical tools inside the MRISRI International · 2026
MDC is building a surgical robot that operates inside an MRITechCrunch · 2024

Leadership at Medical Devices Corner

Mark CutkoskyMark CutkoskyAdvisor
Samuel FrishmanSamuel FrishmanFounder & CEO

Similar to Medical Devices Corner

Minimally Invasive DevicesMinimally Invasive DevicesColumbus, OH, USSurgical Devicesest. 2009Minimally Invasive DevicesColumbus, OH, US · est. 2009

Developing surgical tools for enhanced visualization in minimally invasive surgeries across the US.

Public · $47.1M33
MedroboticsMedroboticsRaynham, MA, USMedical Roboticsest. 2005MedroboticsRaynham, MA, US · est. 2005

US-based Medrobotics develops and commercializes the innovative Flex Robotic System for medical use.

Series B · $206.5M175
AiM Medical RoboticsAiM Medical RoboticsWorcester, MA, USMedical Devicesest. 2018AiM Medical RoboticsWorcester, MA, US · est. 2018

AiM Medical Robotics: Innovating neurosurgery with precise, efficient, portable MRI-functional robots.

Series A · $3.4M30
Mirtle MedicalMirtle MedicalNorth Andover, MA, USMedical Devicesest. 2012Mirtle MedicalNorth Andover, MA, US · est. 2012

MiRTLE Medical: Innovating cardiac monitoring with diagnostic-grade devices and software for enhanced patient care.

Pre-Seed · $1.5M4
Sutro Biopharma
Sutro Biopharma

South San Francisco, CA, US

Board Member· Board
Intuitive Surgical
Intuitive Surgical
Public12.1k1995Sunnyvale, CA, US
Co-Founder

Leadership at Intuitive Surgical

Joe BeeryJoe BeeryBoard Member
Alan J. LevyAlan J. LevyBoard Member
Craig BarrattCraig BarrattBoard Member
Don KaniaDon KaniaBoard Member
Keith LeonardKeith LeonardBoard Member
Gary GuthartGary GuthartCEO
Arixa Pharmaceuticals
Arixa Pharmaceuticals
Seed$13M302016Palo Alto, CA, US
Co-Founder

Leadership at Arixa Pharmaceuticals

Eric GordonEric GordonCo-Founder

Similar to Arixa Pharmaceuticals

Aria PharmaceuticalsAria PharmaceuticalsPalo Alto, CA, USPharmaceuticalsest. 2014Aria PharmaceuticalsPalo Alto, CA, US · est. 2014

Aria Pharmaceuticals: Pioneering novel therapies for complex diseases in preclinical stages.

Series B · $14.3M38
Synereca PharmaceuticalsSynereca PharmaceuticalsChapel Hill, NC, USDrugs, Pharmaceuticalsest. 2017Synereca PharmaceuticalsChapel Hill, NC, US · est. 2017

Synereca Pharmaceuticals innovates orally-active drugs to enhance existing antibiotics' effectiveness.

Pre-Seed · $2.3M6
Taxis PharmaceuticalsTaxis PharmaceuticalsMonmouth Junction, NJ, USPharmaceuticalsest. 2009Taxis PharmaceuticalsMonmouth Junction, NJ, US · est. 2009

TAXIS Pharmaceuticals Inc., a biopharmaceutical firm specializing in developing drugs for resistant bacterial pathogens.

Seed · $6.2M28

John G. Freund's Co-Investors

Stephen HoffmanStephen HoffmanCo-invested · Series B

John G. Freund's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to John G. Freund

Gregory HinckleyGregory HinckleyBoard Member · Bio-RadHelen LohHelen LohBoard Member · Charles SchwabWes JohnsonWes JohnsonBoard Member · AngioDynamicsSarindr BhumiratanaSarindr BhumiratanaCo-Founder · Epi OneMichael SchulerMichael SchulerFounder · Bone BiologicsBrad ValeBrad ValeCo-Founder · Treo Ventures